Matches in Wikidata for { <http://www.wikidata.org/entity/Q92502579> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q92502579 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92502579 description "scientific article published on 20 March 2019" @default.
- Q92502579 description "wetenschappelijk artikel" @default.
- Q92502579 description "наукова стаття, опублікована 20 березня 2019" @default.
- Q92502579 description "գիտական հոդված հրատարակված 2019 թվականի մարտի 20-ին" @default.
- Q92502579 name "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 name "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 type Item @default.
- Q92502579 label "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 label "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 prefLabel "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 prefLabel "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 P1433 Q92502579-5A6CD1D6-D44A-472B-B561-689C3E9564B6 @default.
- Q92502579 P1476 Q92502579-930A2A31-A3CD-4803-BCA7-FAA88F710D03 @default.
- Q92502579 P2093 Q92502579-02533E6D-C6A2-4FBF-A513-ABEA1E13D4D7 @default.
- Q92502579 P2093 Q92502579-18166339-4AAE-4693-8305-439CE566C699 @default.
- Q92502579 P2093 Q92502579-2DE19CD0-B674-4479-A50B-9DBE640306AA @default.
- Q92502579 P2093 Q92502579-33C25BCE-27C5-4115-9557-88DC5200D2C3 @default.
- Q92502579 P2093 Q92502579-4FD669D5-7FD2-4953-869D-FAF6C41BD950 @default.
- Q92502579 P2093 Q92502579-6357739F-A906-48DC-A5F5-837A849203EE @default.
- Q92502579 P2093 Q92502579-65AF388A-2FCE-4FEA-B01C-38190B97726C @default.
- Q92502579 P2093 Q92502579-6A653504-063E-476A-B88C-932CE16DE7B2 @default.
- Q92502579 P2093 Q92502579-8C459D3A-75AA-4711-952D-8409043DF545 @default.
- Q92502579 P2093 Q92502579-9FC1AB84-0EFD-44A1-B140-4E05C70BC08A @default.
- Q92502579 P2093 Q92502579-A6DBD639-BAD7-4C62-BE16-96C2F80A2E93 @default.
- Q92502579 P2093 Q92502579-A87BE799-76E9-44D9-858F-D6F2B3459D6B @default.
- Q92502579 P2093 Q92502579-B51DB52A-B915-4A3F-A26F-BF14BFAB52BF @default.
- Q92502579 P2093 Q92502579-C1383C11-E21D-46CC-97CF-F3A5D44246F5 @default.
- Q92502579 P2093 Q92502579-D0DD74A7-F367-418D-A724-8CD915E94B62 @default.
- Q92502579 P2093 Q92502579-E0EBD38A-2706-4E1F-9ECF-37C8EC9FA2B7 @default.
- Q92502579 P2093 Q92502579-FB81AE4E-E46D-4C7C-B506-4479A7AF88E3 @default.
- Q92502579 P2093 Q92502579-FE8BC2EC-00DB-4BCF-8F25-722618AB61F2 @default.
- Q92502579 P304 Q92502579-3FA00E6C-6D30-44BD-8D69-EAB50714111F @default.
- Q92502579 P31 Q92502579-E58436C2-3D8F-4C82-AB6B-8DFFEA268D68 @default.
- Q92502579 P356 Q92502579-317E7295-D3D7-466F-BE93-09C122169E6C @default.
- Q92502579 P433 Q92502579-2D0F42B8-9E0C-4556-AC82-CF318BDCC8E3 @default.
- Q92502579 P478 Q92502579-9726967C-5E7B-4195-A6E5-E6818919106E @default.
- Q92502579 P50 Q92502579-AF52793C-2280-47E3-A0D4-F1F41812CE10 @default.
- Q92502579 P50 Q92502579-D84EE1A4-9FDF-461A-B42E-67BCD1E5F17E @default.
- Q92502579 P577 Q92502579-FF4CE23A-0F36-4C4A-9B28-B8A6A24AAE4B @default.
- Q92502579 P698 Q92502579-9A976B1D-A70D-4598-B259-089615122A23 @default.
- Q92502579 P921 Q92502579-075C04D3-5832-4D54-AF45-48D6FF1B8942 @default.
- Q92502579 P921 Q92502579-559AFEEB-7937-4DFB-8D9A-B1B19ED87D73 @default.
- Q92502579 P356 JCO.18.01600 @default.
- Q92502579 P698 30892988 @default.
- Q92502579 P1433 Q400292 @default.
- Q92502579 P1476 "Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study" @default.
- Q92502579 P2093 "Ahmed Hamed Salem" @default.
- Q92502579 P2093 "Andrew H Wei" @default.
- Q92502579 P2093 "Anoop Enjeti" @default.
- Q92502579 P2093 "Brenda Chyla" @default.
- Q92502579 P2093 "Gail J Roboz" @default.
- Q92502579 P2093 "Ing Soo Tiong" @default.
- Q92502579 P2093 "Jing-Zhou Hou" @default.
- Q92502579 P2093 "John Hayslip" @default.
- Q92502579 P2093 "Kaffa M Fakouhi" @default.
- Q92502579 P2093 "Relja Popovic" @default.
- Q92502579 P2093 "Rod Humerickhouse" @default.
- Q92502579 P2093 "Roland B Walter" @default.
- Q92502579 P2093 "Sangmin Lee" @default.
- Q92502579 P2093 "Stephen A Strickland" @default.
- Q92502579 P2093 "Suresh Agarwal" @default.
- Q92502579 P2093 "Tu Xu" @default.
- Q92502579 P2093 "Walter Fiedler" @default.
- Q92502579 P2093 "Wan-Jen Hong" @default.
- Q92502579 P304 "1277-1284" @default.
- Q92502579 P31 Q13442814 @default.
- Q92502579 P356 "10.1200/JCO.18.01600" @default.
- Q92502579 P433 "15" @default.
- Q92502579 P478 "37" @default.
- Q92502579 P50 Q80129939 @default.
- Q92502579 P50 Q87654490 @default.
- Q92502579 P577 "2019-03-20T00:00:00Z" @default.
- Q92502579 P698 "30892988" @default.
- Q92502579 P921 Q180983 @default.
- Q92502579 P921 Q264118 @default.